Bristol Myers Squibb SEC filings, summarized
We read every Bristol Myers Squibb 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track BMY in your inbox
Add Bristol Myers Squibb to your watchlist — free, every morning.
Recent filings
Bristol Myers Squibb raises 2026 outlook after second-quarter revenue growth
Bristol Myers Squibb reported second-quarter 2026 revenue of $13.0 billion, up 6% year over year, with non-GAAP EPS of $2.04 and Growth Portfolio revenue up…
Bristol Myers Squibb raises 2026 outlook after second-quarter revenue growth
Bristol Myers Squibb reported second-quarter 2026 revenue of $12.97 billion, up 6% year over year, with non-GAAP EPS of $2.04 and Growth Portfolio revenue…
Bristol-Myers Squibb ($BMY) filed an 8-K (Item 9.01) on Feb 5, 2026 furnishing a press release (Exhibit…
Bristol-Myers Squibb ($BMY) filed an 8-K (Item 9.01) on Feb 5, 2026 furnishing a press release (Exhibit 99.1) and presentation materials (Exhibit 99.2).…
Feb 5, 2026 — $BMY posted a presentation (Ex.
Feb 5, 2026 — $BMY posted a presentation (Ex. 99.2) on bms.com for its Q4 & FY 2025 results; conference call & webcast set for 8:00 AM ET. Presentation…
Bristol-Myers Squibb ($BMY) issued a press release on Feb 5, 2026 announcing Q4 & full‑year 2025 financial…
Bristol-Myers Squibb ($BMY) issued a press release on Feb 5, 2026 announcing Q4 & full‑year 2025 financial results. Earnings Press Release is posted at…
Bristol-Myers Squibb ($BMY) filed a Form 8‑K on Jan 12, 2026 furnishing an investor presentation (Exhibit…
Bristol-Myers Squibb ($BMY) filed a Form 8‑K on Jan 12, 2026 furnishing an investor presentation (Exhibit 99.1) dated Jan 12, 2026 and an Inline XBRL cover…
Bristol-Myers Squibb Company posted an investor presentation to its website on Jan 12, 2026; copy attached…
Bristol-Myers Squibb Company posted an investor presentation to its website on Jan 12, 2026; copy attached as Exhibit 99.1 to Form 8‑K. 📄 $BMY…